U.S. Water Utilities Stock News

NYSE:ATI
NYSE:ATIAerospace & Defense

Stronger Margins And Completed Buyback Could Be A Game Changer For ATI (ATI)

ATI Inc. recently reported past first-quarter 2026 results showing modest sales growth to US$1,151.5 million and higher net income of US$118.2 million, while also completing a US$655.12 million share repurchase program covering 8,819,175 shares since its September 2024 authorization. Together, stronger earnings per share alongside a completed multi-year buyback highlight ATI’s focus on boosting profitability and returning capital to shareholders. With Q1 margin improvement now clear, we’ll...
NYSE:RSG
NYSE:RSGCommercial Services

Does RSG’s Margin Expansion And AI Push Reshape The Bull Case For Republic Services (RSG)?

Republic Services, Inc. recently reported first-quarter 2026 results, with revenue of US$4.11 billion, net income of US$525 million and diluted EPS of US$1.70, while also affirming a quarterly dividend of US$0.625 per share payable on July 15, 2026. The company coupled this earnings performance with margin expansion driven by disciplined pricing and cost control, alongside ongoing investments in AI, digital tools, acquisitions, and fleet electrification aimed at improving efficiency and...
NYSE:ONTO
NYSE:ONTOSemiconductor

What Onto Innovation (ONTO)'s Mixed Q1 Results and Upbeat Q2 Outlook Means For Shareholders

In early May 2026, Onto Innovation Inc. reported first-quarter 2026 results showing sales of US$291.95 million, higher than a year earlier, but with net income dropping to US$33.75 million and diluted earnings per share from continuing operations easing to US$0.67. At the same time, the company issued second-quarter 2026 guidance calling for US$320 million to US$330 million in revenue and GAAP diluted earnings per share of US$1.09 to US$1.18, highlighting management’s confidence despite the...
NYSE:LEG
NYSE:LEGConsumer Durables

A Look At Leggett & Platt (LEG) Valuation After Softer First Quarter 2026 Results

First quarter earnings put Leggett & Platt’s recent performance in focus Leggett & Platt (LEG) reported first quarter 2026 earnings with sales of US$918.2 million and net income of US$20 million, compared with US$1,022.1 million and US$30.6 million a year earlier. These results give you fresh numbers to assess how the bedding, furniture, and engineered components manufacturer is currently performing and how the stock might reflect changes in profitability and scale. See our latest analysis...
NYSE:TAL
NYSE:TALConsumer Services

A Look At TAL Education Group (TAL) Valuation As Analyst Optimism And Ratings Improve

Analyst optimism and recent stock performance Recent analyst optimism around TAL Education Group (NYSE:TAL), including higher earnings estimates and a favorable Zacks Rank #1 rating, has drawn fresh attention to the stock following its recent share price gains. See our latest analysis for TAL Education Group. At a latest share price of US$11.09, TAL’s short term share price has been choppy, with a 1 day move down 2.72% and a 90 day share price return down 9.62%. The 3 year total...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

A Look At Rhythm Pharmaceuticals (RYTM) Valuation After IMCIVREE Approvals And Strong First Quarter Results

Rhythm Pharmaceuticals (RYTM) stock has been in focus after a cluster of catalysts, including U.S. and European approvals for IMCIVREE in acquired hypothalamic obesity, as well as first quarter revenue of US$60.11 million alongside a net loss of US$55.64 million. See our latest analysis for Rhythm Pharmaceuticals. The recent approvals and data updates appear to be feeding into Rhythm Pharmaceuticals’ share price performance, with the stock at US$94.17 and a 7 day share price return of 10.04%...
NasdaqGS:EVCM
NasdaqGS:EVCMSoftware

EverCommerce (EVCM) Valuation Check After AI Progress And Return To Profitability

EverCommerce (EVCM) drew fresh investor attention after reporting first quarter 2026 results with revenue of US$147.47 million and net income of US$7.17 million, compared with a net loss a year earlier. See our latest analysis for EverCommerce. The latest results and progress on AI enabled products have coincided with building momentum in the stock, with a 30 day share price return of 9.62% and a 1 year total shareholder return of 5.28%. If EverCommerce's AI push has caught your eye, it can...
NasdaqGS:SKWD
NasdaqGS:SKWDInsurance

A Look At Skyward Specialty Insurance Group (SKWD) Valuation After Strong Q1 Earnings And Apollo Acquisition Impact

Skyward Specialty Insurance Group (SKWD) has drawn fresh attention after first quarter 2026 earnings showed revenue of US$475.87 million and net income of US$49.73 million. The results reflect contributions from the Apollo acquisition. See our latest analysis for Skyward Specialty Insurance Group. At a share price of US$46.69, the stock has seen a 6.99% 7 day share price return and a 2.59% 1 day share price return around the earnings release, while the 1 year total shareholder return has...
NasdaqCM:HOVR
NasdaqCM:HOVRAerospace & Defense

Should New Horizon Aircraft’s US$19.9 Million Equity Raise to Fund Cavorite X7 Matter to HOVR Investors?

New Horizon Aircraft Ltd. has now completed a registered direct follow-on equity offering, raising approximately US$19.90 million through the sale of 9,254,889 Class A ordinary shares at US$2.15 each, at a small per-share discount, to support its hybrid-electric VTOL development and general corporate needs. This funding round, involving institutional investors and placement agent warrants, is intended to accelerate the Cavorite X7 hybrid-electric VTOL program while temporarily limiting...
NasdaqCM:CLDX
NasdaqCM:CLDXBiotechs

The Bull Case For Celldex Therapeutics (CLDX) Could Change Following Q1 Loss And Barzolvolimab Milestones

Celldex Therapeutics recently reported first-quarter 2026 results, with revenue falling to US$15,000 from US$695,000 a year earlier and net loss widening to US$78.69 million, while accelerating investment in late-stage development of its lead antibody barzolvolimab. At the same time, Celldex completed Phase 3 enrollment for barzolvolimab in chronic spontaneous urticaria six months ahead of plan and raised about US$345 million in a follow-on offering, extending its funding runway for ongoing...
NYSE:SHAK
NYSE:SHAKHospitality

A Look At Shake Shack (SHAK) Valuation After Rare Operating Loss And First Quarter Earnings Miss

Shake Shack (SHAK) has been under pressure after first quarter results fell short on earnings and revenue, producing a rare operating loss as higher costs and regional disruptions weighed on profitability. See our latest analysis for Shake Shack. The sharp post earnings selloff is clear in the 7 day share price return of down 26.61% and 30 day return of down 28.87%. The 1 year total shareholder return of down 37.93% shows pressure has been building for some time, despite a new CFO appointment...
NasdaqGS:FELE
NasdaqGS:FELEMachinery

A Look At Franklin Electric (FELE) Valuation After Reaffirmed 2026 Earnings And Sales Guidance

Franklin Electric (FELE) is back in focus after reporting first quarter 2026 results and reaffirming its full year net sales guidance, prompting investors to reassess the stock’s risk and income profile. See our latest analysis for Franklin Electric. At a share price of $99.34, Franklin Electric’s short term share price performance has been mixed, with the stock down 8.35% over 90 days but supported by a 1 year total shareholder return of 11.99%, suggesting momentum has cooled after earlier...
NYSE:DBD
NYSE:DBDTech

Does VyStar’s AI ATM Deal Deepen Diebold Nixdorf’s Shift To Software-Led Services (DBD)?

In early May 2026, Diebold Nixdorf reported first-quarter revenue of US$891.8 million and net income of US$5 million, while VyStar Credit Union expanded its partnership to adopt Diebold Nixdorf's Branch Automation Solutions and upgrade more than 200 ATMs with DN Series cash-recycling devices and advanced software features. The VyStar rollout highlights how Diebold Nixdorf’s artificial intelligence-driven managed services and analytics are being embedded deeper into client ATM networks,...
NasdaqGM:NBN
NasdaqGM:NBNBanks

A Look At Northeast Bank (NBN) Valuation After Strong Year Over Year Earnings Growth

Key earnings details from Northeast Bank’s latest report Northeast Bank (NBN) posted third quarter results that highlighted year over year changes in profitability, including net interest income of US$63.07 million and net income of US$29.85 million for the period ended March 31, 2026. For the first nine months of the fiscal year, the bank reported net interest income of US$160.07 million and net income of US$73.14 million, giving investors fresh data to assess recent performance and earnings...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

Is Ambarella's (AMBA) CEO Award a Hint About Its Edge AI Moat and Strategy?

Ambarella recently announced that its co‑founder, president and CEO, Fermi Wang, received the inaugural 2026 IEEE Arun N. Netravali Video Analytics, Technology and Systems Award for his work in AI-powered video and edge analytics, underscoring the company’s technical contributions to this field. This recognition puts fresh attention on Ambarella’s edge AI system-on-chip platforms, highlighting how leadership in video analytics and AI processing underpins its semiconductor offering. We’ll now...
NasdaqGM:RLAY
NasdaqGM:RLAYBiotechs

How Relay’s Phase 3 Zovegalisib Breast Cancer Push Could Reshape Relay Therapeutics’ (RLAY) Investment Story

Relay Therapeutics, Inc. recently reported first-quarter 2026 results showing revenue of US$3.00 million and a net loss of US$73.29 million, while outlining plans to advance its lead PI3Ka inhibitor zovegalisib with Pfizer’s atirmociclib into Phase 3 for frontline PI3Ka‑mutated, HR+/HER2- metastatic breast cancer. What stands out is that in heavily pre-treated patients, the zovegalisib triplet regimen showed an objective response rate approaching current first-line doublet therapies, which...
NYSE:PCOR
NYSE:PCORSoftware

A Look At Procore Technologies (PCOR) Valuation After Strong Q1 2026 Results And Raised Guidance

Procore Technologies (PCOR) is back in focus after its first quarter 2026 update, which combined higher revenue, a narrower net loss, raised full year guidance, fresh AI moves, and active share repurchases. See our latest analysis for Procore Technologies. Despite the stronger first quarter story and raised 2026 guidance, Procore Technologies' share price return is down 23.9% year to date and total shareholder return is down 26.2% over the past year. The 1 month share price return of 12.9%...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

Does YouTube Ad Pact And Earnings Beat Change The Bull Case For Sirius XM (SIRI)?

Sirius XM Holdings Inc. reported past first-quarter 2026 results, with revenue of US$2,091 million and net income of US$245 million, alongside higher basic and diluted earnings per share than a year earlier. A new advertising partnership with YouTube, allowing buyers to access YouTube’s audio inventory through Sirius XM’s adtech platform, signals a meaningful shift in how the company can monetize digital audio audiences. We’ll now examine how the YouTube ad partnership, alongside stronger...
NYSE:BF.B
NYSE:BF.BBeverage

Does Brown-Forman (BF.B)’s Control States Shake-Up Reveal a Deeper Distribution Strategy Shift?

In late April 2026, Brown-Forman Corporation announced it had realigned its U.S. control states distribution network, appointing four key distributors across 11 state-managed spirits markets while retaining existing partners in seven others. This reshaping of distributor relationships, following the end of merger discussions with Pernod Ricard, signals Brown-Forman’s focus on sharpening operational efficiency and market reach. We’ll now examine how this control states distribution overhaul...